Researchers in Russia finished Tuesday the early-stage human trials of a second COVID-19 vaccine candidate, according to a report. According to Reuters, “Siberia’s Vector virology institute” wrapped up Phase II, attributing Interfax news agency, which reportedly cited “watchdog” Rospotrebnadzor. The vaccine candidate is reportedly a “peptide-based jab” and began human trials on July 27, involving 100 volunteers, the outlet wrote. "Today ... the final group of 20 volunteers was released from hospital," according to a statement, per Reuters. "All 100 volunteers were vaccinated with two doses and have completed a 23-day monitoring period in hospital.

Source: Fox News September 08, 2020 14:37 UTC